-

Organigram Announces Executive Change

MONCTON, New Brunswick--(BUSINESS WIRE)--Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI) announces that Ray Gracewood, Senior Vice President of Marketing and Communications has left Organigram to pursue other interests.

Organigram would like to thank Mr. Gracewood for his many foundational contributions to the organization and wish him well in his future endeavors. “Ray is a pioneer in cannabis marketing. He has been instrumental in launching Organigram’s medical business and building out its adult-use recreational brand portfolio” said Greg Engel, Chief Executive Officer. During Mr. Gracewood’s tenure Organigram was the recipient of numerous industry awards including most recently the Lift Canadian Cannabis Awards: “Top High THC Oil” and Leafly’s Readers Choice Awards: “Top THC-Dominant Flower - La Strada”, “Top Pre-Roll - El Dorado”, “Top CBD Oil – Edison CBD”, “Top THC Oil – Edison Sativa”.

Julie Chamberlain has been promoted to Vice President of Marketing. Julie joined the Organigram team in August 2019 as the Senior Director of Brand. Julie is a seasoned manager, marketer and brand leader with over 12 years of international experience at L’Oréal including at its Parisienne head office as well as two years as Senior Brands Strategist at Irving Oil. At L’Oréal Ms. Chamberlain most recently served as General Manager for the NYX Professional Division. Julie has proven experience in building high performing teams in consumer packaged goods (CPG) focused on retail, indirect and e-commerce growth.

About Organigram Holdings Inc.:

Organigram Holdings Inc. is a NASDAQ and TSX listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada.

Organigram is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the Company 's global footprint. Organigram has also developed a portfolio of legal adult use recreational cannabis brands including The Edison Cannabis Company, Ankr Organics and Trailblazer. Organigram's primary facility is located in Moncton, New Brunswick and the Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).

For more information about Organigram please visit www.Organigram.ca

Contacts

Investor Relations Enquiries:
Amy Schwalm
Vice President, Investor Relations
(416) 704-9057
Amy.Schwalm@organigram.ca

Media Enquiries:
Marlo Taylor
Gage Communications
mtaylor@gagecommunications.ca

Organigram Holdings Inc.

NASDAQ:OGI

Release Versions
$Cashtags

Contacts

Investor Relations Enquiries:
Amy Schwalm
Vice President, Investor Relations
(416) 704-9057
Amy.Schwalm@organigram.ca

Media Enquiries:
Marlo Taylor
Gage Communications
mtaylor@gagecommunications.ca

More News From Organigram Holdings Inc.

Organigram Announces C$65.2 Million BAT Private Placement Investment in Connection with the Acquisition of Sanity Group

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading global cannabis company, today announced that it has entered into a subscription agreement (the “Subscription Agreement”) with BT DE Investments Inc. ( “BAT”), a wholly-owned subsidiary of British American Tobacco p.l.c. (LSE: BATs and NYSE: BTI), in connection with its previously announced proposed acquisition (the “Acquisition”) of Sanity Group GmbH (“Sanity” or “Sanity Group”...

Organigram Announces Proposed Acquisition of Sanity Group, a Leading German Cannabis Company

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that it has entered into a definitive agreement (the “Purchase Agreement”) to acquire (the “Acquisition”) all the issued and outstanding shares of Sanity Group GmbH (“Sanity” or “Sanity Group”) not currently owned by Organigram. Upon closing of the Acquisition, Organigram will pay shareholders of Sanity (collectively, the “Ve...

Organigram Reports First Quarter Fiscal 2026 Results

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share1, is pleased to announce its results for the first quarter ended December 31, 2025 (“Q1 Fiscal 2026” or "Q1"). Q1 FISCAL 2026 HIGHLIGHTS Gross Revenue: $97.3 million (+46% year-over-year). Net Revenue: $63.5 million (+49% year-over-year). International Revenue: $5.0 million (+51% year-over-year). Adjusted EBITDA2: $5.3 million (+273% year-over-...
Back to Newsroom